Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1248411 | 1.00 | TDP1 (0.34) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| SCHEMBL49617 | 0.92 | TDP1 (0.38) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| SCHEMBL6281632 | 0.90 | TDP1 (0.35) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| SCHEMBL28811735 | 0.90 | TDP1 (0.35) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| SCHEMBL9414101 | 0.90 | TDP1 (0.37) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| SCHEMBL10585317 | 0.90 | TDP1 (0.37) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| Hydrochloric Acid SCHEMBL28497176 | 0.90 | TDP1 (0.37) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| Hydrochloric Acid SCHEMBL28975804 | 0.90 | TDP1 (0.37) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| Bromide SCHEMBL1577209 | 0.90 | TDP1 (0.37) | TDP1TSHRLTA4HPCSK9PTGS2 | |
| SCHEMBL30514704 | 0.90 | TDP1 (0.37) | TDP1TSHRLTA4HPCSK9PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116947696-A | Method for synthesizing adiponitrile by in-situ catalysis | 刘凯凯 | 2023-10-27 | — | — | CN | claimed |
| CN-112079865-B | Phosphine nitrogen ligand with multiple chiral centers and synthetic method and application thereof | 中国科学院上海有机化学研究所 | 2022-03-01 | — | — | CN | claimed |
| CN-112079865-A | Phosphine nitrogen ligand with multiple chiral centers and synthetic method and application thereof | 中国科学院上海有机化学研究所 | 2020-12-15 | — | — | CN | claimed |
| CN-109320559-B | Nickel-palladium metal complex, preparation method and application thereof, product and application thereof | 东华大学 | 2020-10-30 | — | — | CN | claimed |
| CN-111087278-A | Ring-belt arene compound and preparation method and application thereof | 清华大学 | 2020-05-01 | — | — | CN | claimed |
| CN-116947696-A | Method for synthesizing adiponitrile by in-situ catalysis | 刘凯凯 | 2023-10-27 | — | — | CN | disclosed |
| CN-112079865-B | Phosphine nitrogen ligand with multiple chiral centers and synthetic method and application thereof | 中国科学院上海有机化学研究所 | 2022-03-01 | — | — | CN | disclosed |
| CN-112079865-A | Phosphine nitrogen ligand with multiple chiral centers and synthetic method and application thereof | 中国科学院上海有机化学研究所 | 2020-12-15 | — | — | CN | disclosed |
| CN-109320559-B | Nickel-palladium metal complex, preparation method and application thereof, product and application thereof | 东华大学 | 2020-10-30 | — | — | CN | disclosed |
| CN-111087278-A | Ring-belt arene compound and preparation method and application thereof | 清华大学 | 2020-05-01 | — | — | CN | disclosed |
| CN-101910188-B | Process for producing optically active amines | SUMITOMO CHEMICAL CO | 2013-05-08 | — | — | CN | disclosed |
| EP-2246356-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | SUMITOMO CHEMICAL CO (JP) | 2013-04-03 | — | — | EP | disclosed |
| US-20110054171-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-03-03 | — | — | US | disclosed |
| CN-101910188-A | Process for producing optically active amines | SUMITOMO CHEMICAL CO | 2010-12-08 | — | — | CN | disclosed |
| EP-2246356-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | Sumitomo Chemical Company, Limited (JP) | 2010-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054171-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | TYR, ARSA, ODC1 | TDP1 2919/4885TSHR 3018/4885LTA4H 2784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.